Venture Capital Radar Therapeutics Raises $13.4 Million in Seed Funding BERKELEY — Radar Therapeutics, a biotech company developing smart programmable medicines, has completed an oversubscribed… EditorMay 23, 2024
NewsVenture Capital Scale AI Tips the Scales With $1 Billion New Round SAN FRANCISCO — Scale AI, a data foundry for AI, has tipped the scales after… EditorMay 22, 2024
Venture Capital GV, Ballistic Ventures Lead $27 Million Round in WitnessAI SAN MATEO — WitnessAI, creator of the first enablement platform for safe AI use, has… EditorMay 22, 2024
Venture Capital Alkira Closes $100 Million Series C SAN JOSE — Alkira, a provider of on-demand network infrastructure as-a-service, has closed a $100 million Series… EditorMay 20, 2024
Venture Capital WekaIO Secures $140 Million Series E CAMPBELL – WekaIO (WEKA), an AI-native data platform company, has raised $140 million in an… EditorMay 19, 2024May 19, 2024
NewsVenture Capital Harness Raises $150 Million From Silicon Valley Bank SAN FRANCISCO — Harness, operator of a software delivery platform, has raised $150 million in financing from… EditorMay 19, 2024
Venture Capital Vercel Rakes In $250 Million Series E SAN FRANCISCO — Vercel, operator of a Frontend Cloud platform, has secured $250 million in… EditorMay 19, 2024
Venture Capital Sigma Scores Massive $200 Million Investment SAN FRANCISCO — Sigma, a cloud analytics solution, has raised $200 million in Series D… EditorMay 18, 2024
Venture Capital Gorgias Lands $29 Million in Series C-2 Funding SAN FRANCISCO — Gorgias, a customer experience (CX) platform used by more than 15,000 ecommerce… EditorMay 17, 2024
Venture Capital Legion Technologies Reels in $50 Million SANTA CLARA — Legion Technologies, an operator of a workforce management platform (WFM), announced a… EditorMay 13, 2024
Venture Capital Anetac Emerges From Stealth With $16 Million SAN FRANCISCO — Anetac, a Silicon Valley startup protecting companies from blind spots of service accounts… EditorMay 11, 2024
Venture Capital Bluejay Therapeutics Announces $182 Million Series C SAN MATEO — Bluejay Therapeutics, a leader in the development of novel therapeutics, announced the… EditorMay 10, 2024